HAE logo

Haemonetics (HAE) Long Term Liabilities

Annual Total Long Term Liabilities

$935.25 M
+$70.24 M+8.12%

31 March 2024

HAE Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$1.37 B
-$3.11 M-0.23%

28 September 2024

HAE Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HAE Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.1%+60.8%
3 y3 years+12.0%+84.2%
5 y5 years+152.0%+274.2%

HAE Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+40.0%-0.2%+105.4%
5 y5 yearsat high+152.0%-0.2%+274.2%
alltimeall timeat high+8348.5%-0.2%>+9999.0%

Haemonetics Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$1.37 B(-0.2%)
June 2024
-
$1.38 B(+47.1%)
Mar 2024
$935.25 M(+8.1%)
-
Mar 2024
-
$935.25 M(-6.0%)
Dec 2023
-
$995.35 M(+16.6%)
Sept 2023
-
$853.40 M(-0.8%)
June 2023
-
$860.70 M(-0.5%)
Mar 2023
$865.01 M(+29.5%)
$865.01 M(-1.2%)
Dec 2022
-
$875.20 M(+0.1%)
Sept 2022
-
$873.93 M(+0.5%)
June 2022
-
$869.62 M(+30.2%)
Mar 2022
$668.04 M(-20.0%)
$668.04 M(-10.4%)
Dec 2021
-
$745.19 M(-8.5%)
Sept 2021
-
$814.48 M(-8.4%)
June 2021
-
$888.77 M(+6.5%)
Mar 2021
$834.76 M(+106.0%)
$834.76 M(+106.4%)
Dec 2020
-
$404.53 M(-1.7%)
Sept 2020
-
$411.68 M(-1.2%)
June 2020
-
$416.78 M(+2.9%)
Mar 2020
$405.18 M(+9.2%)
$405.18 M(-0.3%)
Dec 2019
-
$406.48 M(+10.8%)
Sept 2019
-
$366.72 M(-2.2%)
June 2019
-
$374.98 M(+1.0%)
Mar 2019
$371.14 M(+270.4%)
$371.14 M(-0.6%)
Dec 2018
-
$373.23 M(-0.5%)
Sept 2018
-
$375.21 M(+0.6%)
June 2018
-
$373.11 M(+272.3%)
Mar 2018
$100.21 M(-65.2%)
$100.21 M(-39.2%)
Dec 2017
-
$164.73 M(-23.4%)
Sept 2017
-
$214.91 M(-21.3%)
June 2017
-
$273.09 M(-5.2%)
Mar 2017
$287.92 M(-30.1%)
$287.92 M(-9.8%)
Dec 2016
-
$319.30 M(-17.5%)
Sept 2016
-
$387.05 M(-3.9%)
June 2016
-
$402.86 M(-2.2%)
Mar 2016
$412.01 M(-12.5%)
$412.01 M(-6.7%)
Dec 2015
-
$441.54 M(-2.7%)
Sept 2015
-
$453.96 M(-2.6%)
June 2015
-
$466.00 M(-1.0%)
Mar 2015
$470.61 M(+2.4%)
$470.61 M(-1.1%)
Dec 2014
-
$475.90 M(-2.6%)
Sept 2014
-
$488.77 M(-1.4%)
June 2014
-
$495.79 M(+7.9%)
Mar 2014
$459.36 M(-10.4%)
$459.36 M(-3.0%)
Dec 2013
-
$473.67 M(-3.3%)
Sept 2013
-
$489.58 M(-5.4%)
June 2013
-
$517.46 M(+0.9%)
Mar 2013
$512.59 M(+973.3%)
$512.59 M(-1.0%)
Dec 2012
-
$517.61 M(-1.7%)
Sept 2012
-
$526.39 M(+979.8%)
June 2012
-
$48.75 M(+2.1%)
Mar 2012
$47.76 M(+24.2%)
$47.76 M(+44.0%)
Dec 2011
-
$33.17 M(-4.2%)
Sept 2011
-
$34.64 M(-8.7%)
June 2011
-
$37.93 M(-1.4%)
Mar 2011
$38.46 M(+17.4%)
$38.46 M(+31.1%)
Dec 2010
-
$29.33 M(-0.9%)
Sept 2010
-
$29.59 M(-3.4%)
June 2010
-
$30.63 M(-6.5%)
Mar 2010
$32.75 M(+93.3%)
$32.75 M(+49.0%)
Dec 2009
-
$21.99 M(-0.2%)
Sept 2009
-
$22.04 M(-8.3%)
June 2009
-
$24.04 M(+41.9%)
Mar 2009
$16.95 M(-0.8%)
$16.95 M(-19.4%)
Dec 2008
-
$21.03 M(+25.8%)
Sept 2008
-
$16.71 M(-1.8%)
June 2008
-
$17.02 M(-0.4%)
DateAnnualQuarterly
Mar 2008
$17.09 M(+54.3%)
$17.09 M(+49.2%)
Dec 2007
-
$11.45 M(+3.8%)
Sept 2007
-
$11.03 M(-28.5%)
June 2007
-
$15.43 M(+39.4%)
Mar 2007
$11.07 M(-34.0%)
$11.07 M(+4.7%)
Dec 2006
-
$10.57 M(-35.2%)
Sept 2006
-
$16.33 M(-2.9%)
June 2006
-
$16.82 M(+0.2%)
Mar 2006
$16.78 M(-32.1%)
$16.78 M(-7.3%)
Dec 2005
-
$18.09 M(-24.8%)
Sept 2005
-
$24.07 M(-0.3%)
June 2005
-
$24.15 M(-2.2%)
Mar 2005
$24.70 M(-22.3%)
$24.70 M(-4.6%)
Dec 2004
-
$25.89 M(-17.1%)
Sept 2004
-
$31.24 M(-0.9%)
June 2004
-
$31.52 M(-0.9%)
Mar 2004
$31.80 M(-10.7%)
$31.80 M(+6.1%)
Dec 2003
-
$29.98 M(-15.8%)
Sept 2003
-
$35.60 M(-0.0%)
June 2003
-
$35.60 M(+0.0%)
Mar 2003
$35.60 M(-19.1%)
$35.60 M(+1.5%)
Dec 2002
-
$35.08 M(-16.1%)
Sept 2002
-
$41.80 M(-0.7%)
June 2002
-
$42.10 M(-4.3%)
Mar 2002
$44.00 M(-12.6%)
$44.00 M(-0.3%)
Dec 2001
-
$44.13 M(-12.5%)
Sept 2001
-
$50.44 M(+0.3%)
June 2001
-
$50.31 M(-0.1%)
Mar 2001
$50.35 M(+15.8%)
$50.35 M(-27.2%)
Dec 2000
-
$69.15 M(+15.9%)
Sept 2000
-
$59.66 M(+3.7%)
June 2000
-
$57.50 M(+32.3%)
Mar 2000
$43.47 M(-33.5%)
$43.47 M(-26.7%)
Dec 1999
-
$59.30 M(-11.1%)
Sept 1999
-
$66.70 M(+2.3%)
June 1999
-
$65.20 M(-0.3%)
Mar 1999
$65.40 M(+2.8%)
$65.40 M(-1.1%)
Dec 1998
-
$66.10 M(+1.2%)
Sept 1998
-
$65.30 M(-0.2%)
June 1998
-
$65.40 M(+2.8%)
Mar 1998
$63.60 M(+158.5%)
$63.60 M(-4.2%)
Dec 1997
-
$66.40 M(-0.4%)
Sept 1997
-
$66.70 M(+33.1%)
June 1997
-
$50.10 M(+103.7%)
Mar 1997
$24.60 M(+0.8%)
$24.60 M(+10.8%)
Dec 1996
-
$22.20 M(+4.7%)
Sept 1996
-
$21.20 M(-2.8%)
June 1996
-
$21.80 M(-10.7%)
Mar 1996
$24.40 M(-36.1%)
$24.40 M(-3.9%)
Dec 1995
-
$25.40 M(-32.6%)
Sept 1995
-
$37.70 M(-13.1%)
June 1995
-
$43.40 M(+13.6%)
Mar 1995
$38.20 M(+79.3%)
$38.20 M(+48.1%)
Dec 1994
-
$25.80 M(+6.6%)
Sept 1994
-
$24.20 M(+14.2%)
June 1994
-
$21.20 M(-0.5%)
Mar 1994
$21.30 M(+41.1%)
$21.30 M(+54.3%)
Dec 1993
-
$13.80 M(-11.0%)
Sept 1993
-
$15.50 M(+4.7%)
June 1993
-
$14.80 M(-2.0%)
Mar 1993
$15.10 M(-9.6%)
$15.10 M(+18.0%)
Dec 1992
-
$12.80 M(+9.4%)
Sept 1992
-
$11.70 M(-37.1%)
June 1992
-
$18.60 M(+11.4%)
Mar 1992
$16.70 M
$16.70 M(-33.5%)
Dec 1991
-
$25.10 M(+36.4%)
Sept 1991
-
$18.40 M(+28.7%)
June 1991
-
$14.30 M

FAQ

  • What is Haemonetics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Haemonetics?
  • What is Haemonetics annual total long term liabilities year-on-year change?
  • What is Haemonetics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Haemonetics?
  • What is Haemonetics quarterly long term liabilities year-on-year change?

What is Haemonetics annual total long term liabilities?

The current annual total long term liabilities of HAE is $935.25 M

What is the all time high annual total long term liabilities for Haemonetics?

Haemonetics all-time high annual total long term liabilities is $935.25 M

What is Haemonetics annual total long term liabilities year-on-year change?

Over the past year, HAE annual total long term liabilities has changed by +$70.24 M (+8.12%)

What is Haemonetics quarterly total long term liabilities?

The current quarterly long term liabilities of HAE is $1.37 B

What is the all time high quarterly long term liabilities for Haemonetics?

Haemonetics all-time high quarterly total long term liabilities is $1.38 B

What is Haemonetics quarterly long term liabilities year-on-year change?

Over the past year, HAE quarterly total long term liabilities has changed by +$519.03 M (+60.82%)